All Disease Treatment & Prevention articles – Page 11
-
NewsGut microbial interactions drive uric acid degradation via a novel mechanism
Scientists have systematically elucidated the complete mechanism through which the fructooligosaccharide-induced “Ligilactobacillus murinus-Anaerotruncus colihominis” axis reduces uric acid (UA) levels and protects the kidneys.
-
NewsWhen it comes to brain health, is microbiome science missing much of the world?
For more than two decades, scientists have uncovered remarkable links between the trillions of microbes living in our gut and the health of our brains. What if much of this science is based on studying only a narrow slice of global diversity?
-
NewsFrog protein could become first antidote to deadly red tide toxin
Red tide algal blooms produce one of the most potent neurotoxins known: saxitoxin, or STX. Researchers have found that a protein called saxiphilin can neutralize saxitoxin in mice, preventing and even reversing otherwise lethal poisoning.
-
NewsROS–Jak2/Stat3 signaling drives HBV-induced liver inflammation
Scientists investigated the mechanisms underlying HBV-induced liver inflammation and identified a reactive oxygen species (ROS)-dependent signaling cascade that activates the Jak2/Stat3 pathway, thereby triggering hepatic inflammatory responses.
-
NewsNovel pathway suggests gut microbiome could be harnessed to lower blood pressure
The gut microbiome could potentially be harnessed to help lower blood pressure, according to a new study that identifies a previously unknown gut microbiota-bile acid signaling pathway targeting hypertension.
-
NewsHow did the COVID-19 pandemic shift seasonal surges of other respiratory diseases?
A new analysis explores what underlies shifts in the timing of seasonal surges of respiratory diseases, as well as shifts in surges of heart-related deaths, that occurred after the COVID-19 pandemic began.
-
NewsResearchers link gut microbe to cancer-fighting immune response
A new study is the first to show metabolites produced by certain bacteria in the gut can positively impact the body’s immune response to cancer.
-
NewsAnother tick-borne disease to avoid: anaplasmosis in Canada
Move over, Lyme disease — there’s another tick-borne disease to worry about in Canada. Anaplasmosis, the second most common tick-borne disease in the country, can cause a range of health issues, including myocarditis, as a practice article shows.
-
NewsGut bacteria linked to malnutrition may pass to younger generations
A new study suggests that an intestinal disorder linked to malnutrition and stunted growth may be transmitted from one generation to the next via the small intestinal microbiome.
-
NewsGut bacteria linked to frailty in older women
Researchers have identified clear links between the composition of gut bacteria and frailty in older women. In cases of high frailty, with an increased risk of illness and death, gut bacterial diversity is lower and function is impaired.
-
NewsResearchers use friendly viruses to tackle inflammatory bowel disease
A research team has developed a targeted approach to treating inflammatory bowel disease (IBD) using bacteriophages, viruses that infect specific bacteria, to disarm harmful microbes without disrupting the broader gut ecosystem.
-
NewsTwo companion papers explain immune ‘exhaustion’ - and how we might prevent it
Chronic and viral infections can literally exhaust certain key cells in the immune system from a constant barrage of attacks. But a new pair of papers has now pointed a way to understand how this exhaustion happens at a molecular level.
-
NewsEye problems after COVID-19 can now be explained
Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden. The study also explains why it has been difficult for sufferers to get help: the abnormal eye behaviour cannot be detected by standard methods. The researchers have developed a diagnostic model to detect ...
-
NewsBrazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment
Following a licensing agreement signed between the Serum Institute of India (SII) and DNDi, a Phase III clinical trial is expected to begin early next year, with the aim of developing a safe, effective, and globally accessible therapeutic for dengue.
-
NewsChikungunya fever: Etiology, pathogenesis, and management, with evidence-based application of traditional Chinese medicine
Traditional Chinese medicine (TCM) offers complementary strategies for acute symptoms and chronic polyarthralgia in Chikungunya infection. A review synthesizes current knowledge on etiology, pathogenesis, clinical features, and management.
-
NewsCommonly used drugs show small benefit for long Covid fatigue
Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long Covid fatigue among people receiving care from specialist long Covid clinics, according to new findings from a large clinical trial.
-
NewsGut microbiota can predict risk of type 2 diabetes years before it develops
The presence of certain bacteria in the gut microbiota, and fluctuations in a person’s metabolism, can be seen in people who go on to develop type 2 diabetes years later, paving the way for identifying people at risk of developing type 2 diabetes at an early stage.
-
NewsA bacterium capable of predicting the course of a disease
A research team made use of the bacterium’s natural capabilities without altering it genetically. Using plasma samples from patients with COVID-19, they were able to distinguish patients likely to develop a mild form of the disease from those at risk of progressing to a severe form.
-
NewsDrug candidate treats severe fatty liver disease by protecting the gut in animal models
Researchers discovered that a potential drug treats severe fatty liver disease by improving gut health. It reversed metabolic dysfunction-associated steatohepatitis (MASH) in animal models by disrupting a disease-driving pathway that links the gut and liver.
-
NewsBronchiectasis and NTM Research Registry data featured in four World Bronchiectasis Conference abstracts
The Bronchiectasis and NTM Association announced that research leveraging data from the Bronchiectasis and NTM Research Registry was featured in four abstracts presented at the World Bronchiectasis Conference.